Advaccine
Chemicals & Related Products · China · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Beijing, Beijing, ChinaWebsite
www.advaccine.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Advaccine
Advaccine is an innovative vaccine company with a high-value prophylactic and therapeutic vaccine pipeline driven by in-house developed technology platforms and industrial manufacturing capabilities. Its pipeline consists of potential first-in-class key assets developed to address diseases caused by SARS-CoV-2, respiratory syncytial virus (RSV) and hepatitis B virus (HBV), which are diseases with huge unmet medical needs. Advaccine is also developing a series of cancer vaccine candidates, covering viral-related oncology, neoantigen-based therapeutic vaccines and tumor-associated antigen therapeutic vaccines.Explore more
Popular SearchesAdvaccineAdvaccine BiotechSIC Code 28,283NAICS Code 32,325Show moreAdvaccine Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Advaccine your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Advaccine is spiking on competitors!
Check if Advaccine has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Advaccine, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Advaccine launches new products
Congratulate Masked Content for being promoted to Masked Content at Advaccine
Funding: Get notified immidiatlly once Advaccine has new funding data
Click to see if Advaccine had a recent Job posting/layoffs
Earning: See what the market has to say on Advaccine recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Advaccine is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Advaccine is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Advaccine.
Advaccine Tech Stack
Advaccine News & Media
Advaccine Announces First Participants Dosed in Phase 2 Study of ADV110 Evaluating Respiratory Syncytial Virus (RSV) Vaccine Candidate in Australia
SUZHOU, China, June 4, 2021 /PRNewswire/ -- Advaccine Biopharmaceuticals ("Advaccine") announces that the first participants have been successfully dosed in its phase 2 study of ADV110, a respiratory syncytial virus (RSV) prophylactic vaccine candidate, in Australia. The phase 2 study is...Inovio: Advaccine Deal Is a Positive but Not a Game Changer, Analyst Says
Inovio Pharmaceuticals’ (INO) 2020 was a tale of two contrasting halves. Shares skyrocketed during the first 6 months as the small vaccine maker entered the Covid-19 vaccine race and caught a ride on investors’ appetite for coronavirus-focused stocks. However, the year’s second half was marred by disappointment as the company failed to keep up with the pace setters. No doubt, in 2021, investors would like a repeat of last year’s initial surge. Meanwhile, on Monday,
Read more news
Top Chemicals & Related Products Companies
See more top companies
Frequently Asked Questions Regarding Advaccine
Sign Up For FreeTo access detailed company insights
Advaccine is an innovative vaccine company with a high-value prophylactic and therapeutic vaccine pipeline driven by in-house developed technology platforms and industrial manufacturing capabilities. Its pipeline consists of potential first-in-class key assets developed to address diseases caused by SARS-CoV-2, respiratory syncytial virus (RSV) and... Read More
